Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0MU8Y | ISIN: ES0157097017 | Ticker-Symbol: E2Z
Tradegate
27.06.25 | 19:56
10,680 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
IBEX MEDIUM CAP
1-Jahres-Chart
ALMIRALL SA Chart 1 Jahr
5-Tage-Chart
ALMIRALL SA 5-Tage-Chart
RealtimeGeldBriefZeit
10,64010,70013:03
10,64010,70027.06.

Aktuelle News zur ALMIRALL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
11.06.ALMIRALL, S.A.: Information on dividend6
04.06.ALMIRALL, S.A.: Information on dividend5
15.05.XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025481Das Instrument B8D CH1107979838 R+S GROUP HOLDI CUM.PREF. EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025 The instrument B8D CH1107979838 R+S GROUP HOLDI...
► Artikel lesen
ALMIRALL Aktie jetzt für 0€ handeln
12.05.Almirall, S.A. reports Q1 results4
12.05.Almirall Q1 2025 slides: Biologics fuel 15% sales growth despite revenue miss5
12.05.Almirall Q1 Results Climb; Sees Sales Growth In FY252
12.05.ALMIRALL, S.A.: Resolutions approved by the Board of Directors1
12.05.ALMIRALL, S.A.: Information on dividends2
12.05.ALMIRALL, S.A.: Information on Dividend calendar1
12.05.Almirall, S.A.: Almirall Q1 2025 Results395Almirall delivers a strong start to 2025: growing Q1 overall sales by 15%, and 23.4% in its European Dermatology business YoY, aligned with the company's sustained growth trajectory Continued...
► Artikel lesen
12.05.ALMIRALL, S.A.: Almirall announces that it will webcast a conference to introduce and explain the first quarter 2025 results2
12.05.ALMIRALL, S.A.: Resolutions approved by the General Shareholders' Meeting 20252
12.05.ALMIRALL, S.A.: Almirall files First Quarter Results presentation for 20253
02.05.Almirall, Biofrontera encourage sun protection in actinic keratosis social media challenge23
01.05.Biofrontera Inc.: Biofrontera and Almirall Launch the Hats On Challenge to Raise Awareness and Support for Actinic Keratosis378The initiative is a social media challenge ahead of Global AK Awareness Day, on May 24, which supports the work of The Skin Cancer Foundation and EuromelanomaThe Hats On Challenge provides an opportunity...
► Artikel lesen
01.04.ALMIRALL, S.A.: Ordinary General Shareholders' Meeting announcement 2025 - Full agenda3
31.03.ALMIRALL, S.A.: Ordinary General Shareholders' Meeting announcement 20251
21.03.Almirall hosts Skin Academy to advance skin science and dermatology treatments1
21.03.Almirall's 16th Skin Academy Brings Together Leading Experts to Advance Skin Science and Treatment Options in Medical Dermatology991Almirall's 16th Skin Academy is a unique opportunity for collaboration in medical dermatology as it brings together leading experts from across the globe to advance science and innovative approaches...
► Artikel lesen
06.03.Almirall, S.A.: Almirall Announces CFO Transition Plan and Appoints Jon U. Garay Alonso as CFO to Succeed Mike McClellan in August 2025731CFO transition plan focusses on business continuity and the company's strong growth trajectory as European leader in medical dermatology Jon U. Garay Alonso has over 25 years of experience...
► Artikel lesen
Weiter >>
41 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1